RAPT Therapeutics Inc. (RAPT)

1.05

-0.09 (-7.89%)

At close: Mar 03, 2025, 3:59 PM

1.05

-0.47%

After-hours: Mar 03, 2025, 04:00 PM EST

RAPT Therapeutics Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17
Net Income	-116.8M	-83.84M	-69.2M	-52.89M	-43M	-36.15M	-29.11M
Depreciation & Amortization	1.22M	1.05M	996K	1.12M	1.33M	1.24M	1.38M
Stock-Based Compensation	17.09M	11.26M	9.95M	8.69M	2.05M	1.17M	716K
Other Working Capital	-1.84M	-5.04M	-5.23M	-46K	3.4M	-691K	-34K
Other Non-Cash Items	-4.06M	2.09M	1.53M	248K	20K	-14K	-9K
Deferred Income Tax	n/a	n/a	n/a	n/a	-11K	17K	15K
Change in Working Capital	5.5M	-1.33M	-4.3M	2.34M	4.13M	784K	-114K
Operating Cash Flow	-97.05M	-70.77M	-61.03M	-40.49M	-35.47M	-32.95M	-27.12M
Capital Expenditures	-1.13M	-845K	-755K	-398K	-888K	-3.5M	-1.12M
Acquisitions	n/a	44.65M	80.59M	87.04M	45K	n/a	n/a
Purchase of Investments	-161.5M	-190.86M	-164.98M	-139.33M	n/a	n/a	n/a
Sales Maturities Of Investments	266.75M	146.21M	84.39M	52.3M	n/a	n/a	n/a
Other Investing Acitivies	n/a	-44.65M	-80.59M	-87.04M	45K	n/a	n/a
Investing Cash Flow	104.13M	-45.49M	-81.35M	-87.44M	-843K	-3.5M	-1.12M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	1.45M	1.39M	2.02M	1.85M	14.38M	105.2M	59.96M
Financial Cash Flow	1.45M	131.18M	141.48M	75.46M	49.9M	52.73M	30.1M
Net Cash Flow	8.53M	14.92M	-891K	-52.47M	13.59M	16.28M	1.85M
Free Cash Flow	-98.17M	-71.62M	-61.78M	-40.89M	-36.36M	-36.45M	-28.25M